Enrolled
Underlined text would be added to current law. Struck-through text would be removed.
| S.B. No. 269 |
| AN ACT | ||
| relating to required reports of certain vaccine-related or | ||
| drug-related adverse events. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Subchapter A, Chapter 161, Health and Safety | ||
| Code, is amended by adding Section 161.0103 to read as follows: | ||
| Sec. 161.0103. REQUIRED REPORT OF CERTAIN VACCINE-RELATED | ||
| ADVERSE EVENTS. (a) In this section, "serious adverse event" means | ||
| an event that: | ||
| (1) results in death; | ||
| (2) is considered life-threatening; | ||
| (3) results in inpatient hospitalization or an | ||
| extension of the duration of an existing hospitalization; | ||
| (4) results in a persistent or significant incapacity | ||
| or substantial disruption of an individual's ability to perform | ||
| normal life functions; | ||
| (5) results in a congenital anomaly or birth defect; | ||
| or | ||
| (6) results in a medically important condition that, | ||
| based on the physician's reasonable medical judgment, may require | ||
| medical or surgical intervention to prevent an outcome described by | ||
| Subdivisions (1) through (5). | ||
| (b) This section applies only to a vaccine that is: | ||
| (1) experimental or investigational; or | ||
| (2) authorized or approved for emergency use by the | ||
| United States Food and Drug Administration. | ||
| (c) Notwithstanding Subsection (b), this section does not | ||
| apply to a vaccine administered as part of a clinical trial. | ||
| (d) Notwithstanding any other law, a physician shall report | ||
| to the federal Vaccine Adverse Event Reporting System any serious | ||
| adverse event the physician's patient suffers if: | ||
| (1) the physician: | ||
| (A) diagnoses the patient with a condition | ||
| related to the serious adverse event; and | ||
| (B) knows the patient received a vaccination to | ||
| which this section applies; and | ||
| (2) the patient suffers the serious adverse event | ||
| before the first anniversary of the date the patient was | ||
| vaccinated. | ||
| (e) A physician who violates this section is subject to: | ||
| (1) for an initial violation, non-disciplinary | ||
| corrective action by the Texas Medical Board; and | ||
| (2) for each subsequent violation, disciplinary | ||
| action by the Texas Medical Board as if the physician violated | ||
| Subtitle B, Title 3, Occupations Code. | ||
| (f) For purposes of non-disciplinary corrective action or | ||
| disciplinary action imposed under Subsection (e), the Texas Medical | ||
| Board may not consider a violation of this section after the third | ||
| anniversary of the date of the violation. The Texas Medical Board | ||
| shall retain information on each violation of this section in the | ||
| physician's permanent record. | ||
| (g) The executive commissioner shall adopt rules necessary | ||
| to implement this section. | ||
| SECTION 2. Subchapter E, Chapter 431, Health and Safety | ||
| Code, is amended by adding Section 431.1145 to read as follows: | ||
| Sec. 431.1145. REQUIRED REPORT OF CERTAIN DRUG-RELATED | ||
| ADVERSE EVENTS. (a) In this section, "serious adverse event" means | ||
| an event that: | ||
| (1) results in death; | ||
| (2) is considered life-threatening; | ||
| (3) results in inpatient hospitalization or an | ||
| extension of the duration of an existing hospitalization; | ||
| (4) results in a persistent or significant incapacity | ||
| or substantial disruption of an individual's ability to perform | ||
| normal life functions; | ||
| (5) results in a congenital anomaly or birth defect; | ||
| or | ||
| (6) results in a medically important medical condition | ||
| that, based on the physician's reasonable medical judgment, may | ||
| require medical or surgical intervention to prevent an outcome | ||
| described by Subdivisions (1) through (5). | ||
| (b) This section applies only to a drug that is: | ||
| (1) experimental or investigational; or | ||
| (2) authorized or approved for emergency use by the | ||
| United States Food and Drug Administration. | ||
| (c) Notwithstanding Subsection (b), this section does not | ||
| apply to a drug that is administered or used as part of a clinical | ||
| trial. | ||
| (d) Notwithstanding any other law, a physician shall report | ||
| to the United States Food and Drug Administration through the | ||
| MedWatch reporting program any serious adverse event the | ||
| physician's patient suffers if: | ||
| (1) the physician: | ||
| (A) diagnoses the patient with a condition | ||
| related to the serious adverse event; and | ||
| (B) knows the patient was administered or used a | ||
| drug to which this section applies; and | ||
| (2) the patient suffers the serious adverse event | ||
| before the first anniversary of the date the patient was | ||
| administered or used the drug. | ||
| (e) A physician who violates this section is subject to: | ||
| (1) for an initial violation, non-disciplinary | ||
| corrective action by the Texas Medical Board; and | ||
| (2) for each subsequent violation, disciplinary | ||
| action by the Texas Medical Board as if the physician violated | ||
| Subtitle B, Title 3, Occupations Code. | ||
| (f) For purposes of non-disciplinary corrective action or | ||
| disciplinary action imposed under Subsection (e), the Texas Medical | ||
| Board may not consider a violation of this section after the third | ||
| anniversary of the date of the violation. The Texas Medical Board | ||
| shall retain information on each violation of this section in the | ||
| physician's permanent record. | ||
| (g) The executive commissioner shall adopt rules necessary | ||
| to implement this section. | ||
| SECTION 3. As soon as practicable after the effective date | ||
| of this Act, the executive commissioner of the Health and Human | ||
| Services Commission shall adopt rules necessary to implement the | ||
| changes in law made by this Act. | ||
| SECTION 4. This Act takes effect September 1, 2025. | ||
| ______________________________ | ______________________________ | |
| President of the Senate | Speaker of the House | |
| I hereby certify that S.B. No. 269 passed the Senate on | ||
| April 24, 2025, by the following vote: Yeas 31, Nays 0; and that | ||
| the Senate concurred in House amendment on May 26, 2025, by the | ||
| following vote: Yeas 31, Nays 0. | ||
| ______________________________ | ||
| Secretary of the Senate | ||
| I hereby certify that S.B. No. 269 passed the House, with | ||
| amendment, on May 22, 2025, by the following vote: Yeas 104, | ||
| Nays 37, three present not voting. | ||
| ______________________________ | ||
| Chief Clerk of the House | ||
| Approved: | ||
| ______________________________ | ||
| Date | ||
| ______________________________ | ||
| Governor |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.